Incidence, mortality, and DALYs of global pharyngeal cancer: systematic analysis and projections Based on global burden of disease study 2021
- PMID: 40827424
- PMCID: PMC12366512
- DOI: 10.1080/07853890.2025.2547092
Incidence, mortality, and DALYs of global pharyngeal cancer: systematic analysis and projections Based on global burden of disease study 2021
Abstract
Introduction: Compared to other head and neck cancers, pharyngeal cancer (PC) has poorer survival, representing a significant health burden. This study aimed to assess the burden and trends of PC at global, regional, and national levels and analyze mortality-related factors.
Methods: Data on PC, including incidence, mortality, disability-adjusted life-years (DALYs), and death-related risk factors from 1990 to 2021, were obtained from the Global Burden of Disease Study 2021. Estimated annual percentage changes (EAPCs) were calculated to assess trends.
Results: In 2021, PC incidence was 169,820, with 98,435 deaths and 2,843,781 DALYs. Age-standardized rates for incidence, death, and DALYs were 1.93, 1.13, and 32.30 per 100,000, respectively. South Asia had the highest death and DALYs rates (3.23 and 93.00). Low-middle socio-demographic index (SDI) regions showed the highest death rate (2.19) and the greatest EAPC for death rates (0.684%). A positive correlation between SDI and death rates was observed globally (R = 0.26, p < 0.05), particularly in males (R = 0.3, p < 0.05), but not in females. Males exhibited a trend toward younger ages at death by aclohol, peaking in the 35-39-year group.
Conclusion: In 2021, global PC incidence, deaths, and DALYs increased significantly, with notable regional disparities, especially in low-middle SDI regions. Alcohol-related mortality disproportionately affected younger males. Strengthening oral health resources, controlling alcohol and tobacco use are essential to reducing the global PC burden.
Keywords: Global burden of disease study; death; disability-adjusted life-years; incidence; pharyngeal cancer.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures






Similar articles
-
Global, regional, and national burden of male breast cancer and predictions in the next 30 years: a systematic analysis of the global burden of disease study 2021.BMC Cancer. 2025 Aug 20;25(1):1344. doi: 10.1186/s12885-025-14681-0. BMC Cancer. 2025. PMID: 40835916 Free PMC article.
-
Global, regional, and national burden of thyroid cancer in women of child-bearing age, 1990 to 2021 and predictions to 2035: An analysis of the global burden of disease study 2021.Front Endocrinol (Lausanne). 2025 Jun 27;16:1555841. doi: 10.3389/fendo.2025.1555841. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40655400 Free PMC article.
-
Global, regional, and national burden of maternal disorders, 1990-2021: a systematic analysis from the global burden of disease study 2021.BMC Public Health. 2025 Jul 29;25(1):2576. doi: 10.1186/s12889-025-23814-w. BMC Public Health. 2025. PMID: 40730990 Free PMC article.
-
Global burden and risk factors of musculoskeletal disorders among adolescents and young adults in 204 countries and territories, 1990-2019.Autoimmun Rev. 2023 Aug;22(8):103361. doi: 10.1016/j.autrev.2023.103361. Epub 2023 May 23. Autoimmun Rev. 2023. PMID: 37230312 Review.
-
Burden of inflammatory bowel disease among elderly, 1990-2019: A systematic analysis based on the global burden of disease study 2019.Autoimmun Rev. 2025 Jan 31;24(2):103708. doi: 10.1016/j.autrev.2024.103708. Epub 2024 Nov 23. Autoimmun Rev. 2025. PMID: 39586389
References
-
- Cunha ARd, Compton K, Xu R, et al. The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2023;9(10):1401–1416. doi: 10.1001/jamaoncol.2023.2960. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical